Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Shares Issued (2020 - 2024)

Historic Shares Issued for Bolt Biotherapeutics (BOLT) over the last 5 years, with Q4 2024 value amounting to $29000.0.

  • Bolt Biotherapeutics' Shares Issued fell 7264.15% to $29000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $135000.0, marking a year-over-year decrease of 4600.0%. This contributed to the annual value of $108000.0 for FY2024, which is 5731.23% down from last year.
  • Per Bolt Biotherapeutics' latest filing, its Shares Issued stood at $29000.0 for Q4 2024, which was down 7264.15% from $106000.0 recorded in Q4 2023.
  • Bolt Biotherapeutics' 5-year Shares Issued high stood at $245.0 million for Q1 2021, and its period low was -$672000.0 during Q2 2021.
  • Over the past 5 years, Bolt Biotherapeutics' median Shares Issued value was $106000.0 (recorded in 2023), while the average stood at $22.3 million.
  • Data for Bolt Biotherapeutics' Shares Issued shows a peak YoY increase of 72045294.12% (in 2021) and a maximum YoY decrease of 1354000.0% (in 2021) over the last 5 years.
  • Bolt Biotherapeutics' Shares Issued (Quarter) stood at $78000.0 in 2020, then plummeted by 961.54% to -$672000.0 in 2021, then surged by 121.43% to $144000.0 in 2022, then decreased by 26.39% to $106000.0 in 2023, then plummeted by 72.64% to $29000.0 in 2024.
  • Its last three reported values are $29000.0 in Q4 2024, $106000.0 for Q4 2023, and $144000.0 during Q4 2022.